Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) EBITDA (2016 - 2025)

Historic EBITDA for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to -$2.6 million.

  • Sensus Healthcare's EBITDA fell 27183.95% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 14549.03%. This contributed to the annual value of $8.1 million for FY2024, which is 221780.1% up from last year.
  • Latest data reveals that Sensus Healthcare reported EBITDA of -$2.6 million as of Q3 2025, which was down 27183.95% from -$1.9 million recorded in Q2 2025.
  • Sensus Healthcare's EBITDA's 5-year high stood at $5.6 million during Q4 2023, with a 5-year trough of -$2.9 million in Q1 2023.
  • Its 5-year average for EBITDA is $1.0 million, with a median of $1.5 million in 2024.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 196964.98% in 2021, then crashed by 27183.95% in 2025.
  • Over the past 5 years, Sensus Healthcare's EBITDA (Quarter) stood at $5.3 million in 2021, then dropped by 21.56% to $4.2 million in 2022, then skyrocketed by 33.68% to $5.6 million in 2023, then crashed by 69.05% to $1.7 million in 2024, then tumbled by 248.84% to -$2.6 million in 2025.
  • Its EBITDA was -$2.6 million in Q3 2025, compared to -$1.9 million in Q2 2025 and -$2.6 million in Q1 2025.